A new study by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute demonstrated that RNA nanoparticles have elastic and rubbery properties.
Navigating a cancer diagnosis is difficult, and even more so during a global pandemic.
Emily S. Tonorezos was named director of the NCI Office of Cancer Survivorship.
Electra D. Paskett was named director of the Alliance Cancer Control Program and principal investigator for the Alliance NCORP Research Base.
The Association of Community Cancer Centers has named five recipients of the tenth annual ACCC Innovator Awards, highlighting the year's leading-edge strategies to challenges faced by oncology programs and practices across the country.
NIH has awarded seven contracts to companies and academic institutions to develop digital health solutions that help address the COVID-19 pandemic.
Lois B. Travis, the Lawrence H. Einhorn Professor of Cancer Research at IU School of Medicine, has been awarded a five-year, $5.7 million NCI grant to evaluate long-term health outcomes for cancer patients who receive platinum-based chemotherapies.
A new $3.7 million grant, as part of the Beau Biden Cancer Moonshot Initiative, will support a clinical trial designed to test a personalized family genetic risk navigation support platform.
Yale Cancer Center has received an Exploratory Developmental Grant from NIH to fund 3D gene imaging research.
Yale Cancer Center has received a one-year, $175,000 research grant from the Breast Cancer Research Foundation to study reducing re-excisions for breast conserving therapy for women following surgery for breast cancer.
